Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1302-2021Class II

In-View Clear Leggings Bulk Non-Sterile

Medtronic, Inc. / initiated 2021-02-25 / Terminated / root cause: manufacturing process

Cardinal Health 200, LLC began a recall of In-View Clear Leggings Bulk Non-Sterile on . FDA classified it as Class II and gives the reason as "Cardinal Health has determined that a manufacturing variance in a plastic film used to manufacture these products is causing the drapes and leggings to stick , which may prevent the products from being unfolded and...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1302-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic, Inc.
Product
In-View Clear Leggings Bulk Non-Sterile
Product code
ILG Stocking, Elastic
Reason for recall
Cardinal Health has determined that a manufacturing variance in a plastic film used to manufacture these products is causing the drapes and leggings to stick , which may prevent the products from being unfolded and applied properly.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
A Recall notification letter titled, "URGENT MEDICAL DEVICE RECALL" was sent to consignees on 02/25/2021 via FedEx priority overnight. The consignee is requested to follow the following instructions: 1. CHECK all storage and usage locations to confirm whether they have any units of the affected product codes and lot numbers listed in Attachment 1. 2. SEGREGATE and QUARANTINE all impacted on-hand product. 3) RETURN the enclosed acknowledgment form via facsimile (847-689-9101 or 614-652-9648) or email ([email protected]) and indicate the product code, lot and quantity of product they have quarantined. They are requested to please respond regardless of whether or not they have affected product. 4. NOTIFY any customers to whom they may have distributed, or forwarded product affected by this recall. The consignee's notification to their customers may be enhanced by including a copy of this recall notification letter. 5. CONTACT the appropriate Customer Service group to arrange for return and credit/replacement of any affected product. 6. CUSTOMERS that did not receive product directly from Cardinal Health should return product through the location where they purchased it.
Quantity in commerce
21343 units
Distribution
Distributed nationwide to AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV. Distributed also to Australia and Canada.
Product codes and lots
Catalog Number 8430NA; Lot number's: 2460DR2, 2550DR1, 2660DR1, 2470DR2, 2580DR1, 2690DR1, 2480DR2, 2580DR2, 2720DR1, 2520DR1, 2600DR1, 2730DR1, 2530DR1, 2600DR1, 3290DR1, 2540DR1, 2610DR1 3310DR1, 2540DR2, 2650DR1, 3440DR1

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1302-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1300-2021Class IITerminatedVoluntary: Firm initiated
Z-1301-2021Class IITerminatedVoluntary: Firm initiated
Z-1302-2021Class IITerminatedVoluntary: Firm initiated
Z-1303-2021Class IITerminatedVoluntary: Firm initiated
Z-1304-2021Class IITerminatedVoluntary: Firm initiated